ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Interventional Pain Medicine

Top Interventional Pain Medicine Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SHOBHANA PATODIA MD

Interventional Pain Medicine

3,711

$211K

238
105 are 65+

49%
patients receiving schedule two controlled substances

Avg: 32%

43%
patients receiving schedule three controlled substances

Avg: 44%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 21%

$57
Average prescription price

Avg: $82

RALPH CARBONE DO

Interventional Pain Medicine

3,036

$312K

203
39 are 65+

70%
patients receiving schedule two controlled substances

Avg: 32%

48%
patients receiving schedule three controlled substances

Avg: 44%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 21%

$103
Average prescription price

Avg: $82

TIMOTHY LUBENOW

Interventional Pain Medicine

2,868

$362K

307
105 are 65+

48%
patients receiving schedule two controlled substances

Avg: 32%

34%
patients receiving schedule three controlled substances

Avg: 44%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 21%

$126
Average prescription price

Avg: $82

RAMSIN BENYAMIN MD, DABPM, FIPP

Interventional Pain Medicine

2,619

$234K

386
183 are 65+

45%
patients receiving schedule two controlled substances

Avg: 32%

41%
patients receiving schedule three controlled substances

Avg: 44%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 21%

$89
Average prescription price

Avg: $82

LUZ FELDMANN M.D.

Interventional Pain Medicine

2,416

$197K

327
277 are 65+

18%
patients receiving schedule two controlled substances

Avg: 32%

44%
patients receiving schedule three controlled substances

Avg: 44%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 21%

$81
Average prescription price

Avg: $82

RANDOLPH CHANG MD

Interventional Pain Medicine

2,202

$265K

346
269 are 65+

11%
patients receiving schedule two controlled substances

Avg: 32%

18%
patients receiving schedule three controlled substances

Avg: 44%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

48%
prescriptions for brand name drugs

Avg: 21%

$120
Average prescription price

Avg: $82

ATIQ REHMAN M.D.

Interventional Pain Medicine

2,181

$185K

257
119 are 65+

44%
patients receiving schedule two controlled substances

Avg: 32%

53%
patients receiving schedule three controlled substances

Avg: 44%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 21%

$85
Average prescription price

Avg: $82

GARY KOEHN MD, PHD

Interventional Pain Medicine

1,914

$135K

240
141 are 65+

42%
patients receiving schedule two controlled substances

Avg: 32%

59%
patients receiving schedule three controlled substances

Avg: 44%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 21%

$71
Average prescription price

Avg: $82

TODD HAGLE M.D.

Interventional Pain Medicine

1,736

$134K

184
81 are 65+

26%
patients receiving schedule two controlled substances

Avg: 32%

39%
patients receiving schedule three controlled substances

Avg: 44%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 21%

$77
Average prescription price

Avg: $82

NAVEEN TIPIRNENI M.D.

Interventional Pain Medicine

1,561

$103K

316
270 are 65+

33%
patients receiving schedule two controlled substances

Avg: 32%

16%
patients receiving schedule three controlled substances

Avg: 44%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 21%

$66
Average prescription price

Avg: $82

SANDEEP AMIN MD

Interventional Pain Medicine

1,552

$142K

239
77 are 65+

43%
patients receiving schedule two controlled substances

Avg: 32%

32%
patients receiving schedule three controlled substances

Avg: 44%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 21%

$91
Average prescription price

Avg: $82

SUNDARARAJ CHERALA MD

Interventional Pain Medicine

1,527

$73.2K

195
135 are 65+

31%
patients receiving schedule two controlled substances

Avg: 32%

41%
patients receiving schedule three controlled substances

Avg: 44%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

10%
prescriptions for brand name drugs

Avg: 21%

$48
Average prescription price

Avg: $82

YUAN CHEN M.D.

Interventional Pain Medicine

1,501

$74.1K

225
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 32%

12%
patients receiving schedule three controlled substances

Avg: 44%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 21%

$49
Average prescription price

Avg: $82

MATTHEW JAYCOX M.D.

Interventional Pain Medicine

1,496

$138K

219
61 are 65+

51%
patients receiving schedule two controlled substances

Avg: 32%

37%
patients receiving schedule three controlled substances

Avg: 44%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 21%

$92
Average prescription price

Avg: $82

STUART KING MD

Interventional Pain Medicine

1,415

$95.2K

203
112 are 65+

35%
patients receiving schedule two controlled substances

Avg: 32%

56%
patients receiving schedule three controlled substances

Avg: 44%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 21%

$67
Average prescription price

Avg: $82

FAROOQ KHAN MD

Interventional Pain Medicine

1,344

$109K

162
100 are 65+

40%
patients receiving schedule two controlled substances

Avg: 32%

48%
patients receiving schedule three controlled substances

Avg: 44%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 21%

$81
Average prescription price

Avg: $82

JOHN HONG M.D.

Interventional Pain Medicine

1,231

$133K

122
58 are 65+

48%
patients receiving schedule two controlled substances

Avg: 32%

52%
patients receiving schedule three controlled substances

Avg: 44%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 21%

$108
Average prescription price

Avg: $82

JOEL SEE M.D.

Interventional Pain Medicine

1,197

$69.2K

162
118 are 65+

19%
patients receiving schedule two controlled substances

Avg: 32%

62%
patients receiving schedule three controlled substances

Avg: 44%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 21%

$58
Average prescription price

Avg: $82

MARIA ESTILO MD

Interventional Pain Medicine

1,154

$50.6K

97
29 are 65+

60%
patients receiving schedule two controlled substances

Avg: 32%

57%
patients receiving schedule three controlled substances

Avg: 44%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 21%

$44
Average prescription price

Avg: $82

ELAINE OLSON MD

Interventional Pain Medicine

1,148

$224K

72
25 are 65+

67%
patients receiving schedule two controlled substances

Avg: 32%

43%
patients receiving schedule three controlled substances

Avg: 44%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 21%

$195
Average prescription price

Avg: $82

SULEIMAN SALMAN DO

Interventional Pain Medicine

1,063

$79.4K

203
142 are 65+

16%
patients receiving schedule two controlled substances

Avg: 32%

35%
patients receiving schedule three controlled substances

Avg: 44%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 21%

$75
Average prescription price

Avg: $82

RONALD KLOC D.O.

Interventional Pain Medicine

1,028

$43.6K

161
99 are 65+

14%
patients receiving schedule two controlled substances

Avg: 32%

43%
patients receiving schedule three controlled substances

Avg: 44%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 21%

$42
Average prescription price

Avg: $82

BENJAMIN TAIMOORAZY MD

Interventional Pain Medicine

948

$38.8K

104
49 are 65+

29%
patients receiving schedule two controlled substances

Avg: 32%

49%
patients receiving schedule three controlled substances

Avg: 44%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 21%

$41
Average prescription price

Avg: $82

HOWARD DEDES M.D.

Interventional Pain Medicine

932

$42.1K

229
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 32%

11%
patients receiving schedule three controlled substances

Avg: 44%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 21%

$45
Average prescription price

Avg: $82

JARED KALINA DO

Interventional Pain Medicine

928

$105K

115
46 are 65+

50%
patients receiving schedule two controlled substances

Avg: 32%

42%
patients receiving schedule three controlled substances

Avg: 44%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 21%

$113
Average prescription price

Avg: $82

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank